Modern Diagnostic and Research Centre IPO Listing Date: 5 key things retail investors should know before BSE SME debut

With the Modern Diagnostic and Research Centre share listing just around the corner, here are the key things you should know.

Modern Diagnostic and Research Centre IPO: Subscription details

The initial share sale got subscribed a massive 350.49 times, as investors applied for 1,02,95,90,400 shares as against 29,37,600 shares on offer, as per the BSE data.

Qualified institutional buyers (QIBs) subscribed their portion 193.51 times. They applied for 15,14,00,000 shares as compared to 7,82,400 shares on offer.

The non-institutional investors quota was booked 519.38 times, as they submitted applications for 41,13,45,600 shares against 7,92,000 shares on offer.

Individual investors placed bids for 46,68,44,800 shares compared to 13,63,200 shares reserved. This reflects a subscription of 342.46 times.

Modern Diagnostic IPO objectives

The initial share sale sought to raise ₹36.89 crore by offering 40.99 lakh new shares, with no offer for sale (OFS) component.

The fresh issue proceeds will be allocated towards the purchase of medical equipment for diagnostic centres and laboratories, debt clearance, working capital needs and general corporate purposes.

Modern Diagnostic and Research Centre IPO: Share credit, refund and listing date

For investors who secured the Modern Diagnostic and Research Centre IPO allotment, the equity shares will be credited to their Demat account on Tuesday, January 6. Refunds for unsuccessful investors will also be processed on the same day.

The Modern Diagnostic and Research Centre IPO share listing on the BSE SME platform will occur on Wednesday, January 7, 2026, at 10 am.

Modern Diagnostic and Research Centre IPO: Financials

Modern Diagnostic IPO GMP